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Summary Noradrenaline induced changes in the distribution of blood flow in implanted tumour and normal
liver tissue was measured using blood flow tracer microspheres. The ratio of embolised microspheres in
tumour compared to normal tissue was determined before and after the intravenous infusion of
noradrenaline, propranolol and a combination of the two drugs. The ratio was significantly decreased by
noradrenaline alone but significantly increased when propranolol was added to the infusate. Propranolol had
no effect on the ratio. The drug combination increased the tumour to normal ratio by approximately 69%
and also doubled the proportion of microspheres entering the internal tumour circulation. This represents an
enhanced relative blood supply to tumour and would provide a means of preferential carriage of blood borne
cytotoxic agents to tumour tissue rather than normal tissue.
Localised internal radiation therapy is a promising new
treatment modality for the management of hepatic
metastases (Chamberlain et al., 1983). The method requires
the intrahepatic-arterial injection of a suspension of
radioactive microspheres. These microspheres have the high
energy, short range isotope Yttrium 90 incorporated into
their polymer matrix. The microspheres are sized to embolise
in the precapillary vasculature of the liver and resident
tumour tissue.
The efficacy of this form of treatment relies on the largest
possible number of microspheres becoming embolised in
tumour tissue rather than in normal tissue. This criterion
may already be satisfied by the hepatic vasculature where up
to 80% of tumour blood supply stems from the hepatic
artery while only 30% of the supply feeds the normal hepatic
parenchyma. However, recent investigations have shown that
angiotensin II has the ability to dramatically alter the
distribution of blood within the liver to further favour
tumour tissue (Burton et al., 1985). The rationale for this
preferential redistribution is that neoplastic vessels lack the
ability to react to vasoactive agents (Wickersham et al.,
1977) so the tumour blood supply is maintained during the
influence of vasoactive agents acting on normal vessels.
The potential of angiotensin II for extended redistribution
of blood flow during operation is, however, diminished by
reports of hepatic tachyphylaxis (Khairallah et al., 1966;
Richardson & Withrington 1977a). Noradrenaline has been
postulated as a suitable alternative vasoconstricting agent
within the normal liver vasculature (Richardson &
Withrington, 1981). In addition to its vasoconstricting alpha
action, noradrenaline interacts with beta-adrenoceptors
causing hepatic arterial vasodilation. Beta blockade will
increase the hepatic arterial vasoconstrictor potency of
noradrenaline and abolish any secondary vasodilator
response (Hanson, 1973).
As part of an overall research program into the
therapeutic effectiveness of internal radiation therapy
utilising Yttrium 90 microspheres we have studied the effect
of concurrent vasoconstrictor infusion. We have examined
the ability of noradrenaline in the presence of propranolol to
selectively enhance the tumour entrapment of arterially




Twenty seven New Zealand white rabbits with a mean body
weight of 2.68 +0.49 kg had small segments (1 mm3) of VX2
carcinoma implanted into both the left and right medial
lobes of the liver 11-14 days prior to experimentation. This
tumour, from the Australian National University, Canberra,
has been used extensively by our group and has been
described elsewhere (Stribley et al., 1983). All resultant
tumour growths were tested individually. However, one
tumour implant from each of 8 rabbits failed to develop and
was not included in the study.
At the time of final operation the diameter of the tumours
was between 5 and 8 mm. Nineteen of the tumours had
developed areas of central necrosis.
Radioactive microspheres
Commercially produced (Nentrac; New England Nuclear
Co.) polystyrene copolymer tracer microspheres were used to
mimic the distribution of the similar Yttrium 90 therapeutic
microspheres produced in our laboratory. Blood flow tracers
of 15gm diam. were labelled with either cobalt 57 or tin 113.
Each animal was injected with 3 x 106 of both cobalt and
tin labelled microspheres in heparinised saline. Tissue
samples were counted in a Packard 3 channel gamma-
counter with sample size maintained constant to minimise
geometrical errors. The ratio of microspheres per unit weight
embolised in tumour tissue compared to normal hepatic
tissue (T/N ratio) was determined under control conditions
using tin 113 labelled microspheres and, after infusion of one
of the drugs, using cobalt 57 labelled microspheres. The T/N
ratio was determined for each animal by sampling of tissue
after both sets of microspheres had been injected into the
animal.
Procedure
Under halothane-nitrous oxide anaesthesia, polyethylene
catheters (outside diam. 1 mm, inside diam. 0.5 mm) were
introduced into the ascending aorta via the right carotid
artery and also into the femoral vein of each animal. The
carotid cannula allowed both injection of the microspheres
into the systemic arterial circulation and provided a means
of monitoring arterial blood pressure. The femoral cannula
was used for administration of drugs.
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The experimental protocol was split into 4 sections:
(a) the determination of the T/N ratio following infusion
of propranolol alone compared to a saline control
infusion,
(b) the determination of the T/N ratio following infusion
of noradrenaline alone compared to control,
(c) the determination of the T/N ratio following infusion
of a combination solution of noradrenaline and
propranolol compared to control,
(d) the determination of the T/N ratio following infusion
of a combination solution of noradrenaline and
propranolol compared to a previous infusion of
noradrenaline.
At the commencement of each experiment, normal saline
was infused (0.5-1.Omlmin-1) for the control measurement.
When the blood pressure was shown to be constant for at
least 5min the first injection of microspheres was introduced
into the aorta over a period of -30 sec. The blood pressure
was again monitored following the injection and
noradrenaline infused until the sytemic blood pressure was
increased to 25% above control levels in each animal. The
dose of noradrenaline required to achieve this increment was
- 3 pgkg1mmin- and was maintained for - 10min. In the
case of propranolol, which did not influence the blood
pressure, when infused either alone or in conjunction with
noradrenaline, the dose was - 2pgkg-1 min- I over 5-
10min. When the blood pressure was steady the second
microsphere injection was made and the catheter and
stopcock flushed twice with 0.4ml of normal saline.
Ten minutes after the final injection, the animals were
sacrificed and the liver and kidneys were removed and fixed
in 10% buffered formalin. Samples of renal cortex from each
kidney were taken to compare the relative magnitude of
counts in each kidney. This provided a measure of
microsphere mixing in the blood. At least 70 liver samples
weighing 0.1-0.2g were taken from (a) the central portions
of the tumours showing regions of relative necrosis, (b) from
the growing edge of the tumours, and (c) from the rest of
the normal liver tissue. The number of tumours with the
characteristics of central necrosis (i.e. (a)) were 5 for
noradrenaline, 4 for propranolol, 6 for the noradrenaline
preceded drug combination treatment group. The specific
activity of each sample was measured and the mean+s.d. for
each liver compartment was calculated for determination of
the control and drug induced T/N ratio. In addition, from
the normal liver samples, the coefficient of variation
(standard deviation/mean) was also determined as a measure
of homogeneity of distribution of microspheres.
Statistics
The T/N ratio under control conditions was compared to the
ratio after drug infusion using the Wilcoxon signed rank test
for paired samples. This test was also used to determine
differences in the ratio of microspheres lodged in the tumour
centre compared to normal tissue, the percentage coefficient
of variation and the renal embolisation ofmicrospheres.
Results
It was found that the initial control injection of microspheres
did not alter the blood pressure or heart rate of any of the
animals prior to the infusion of subsequent drugs and
injection of the next set of microspheres. There were also no
visible- signs of distress in the rabbits after the surgical
manipulation or infusion of the drugs at the doses described.
The tumours examined from each group were of similar size.
Tumour to normal tissue embolisation ratio
The infusion of noradrenaline alone had a negative effect on
the T/N ratio compared to control infusion. The mean
control ratio of 26:1 was significantly (P<O.O1) reduced to
17: 1. This represented a 29% decrease in the ratio as
displayed in Figure 1. Propranolol alone also reduced the
T/N ratio from a control of 29:1 to 22:1 but this was not
statistically significant (P>0.05, Figure 2).
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Figure 1 Changes in the tumour to normal liver tissue ratio in
rabbits after the infusion of noradrenaline. Solid squares indicate
group means.
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Figure 2 Changes in the tumour to normal liver tissue ratio in
rabbits after the infusion of propranolol.
The addition of the two drugs however, induced a
significant increase (P<0.01) in the T/N ratio from the
saline control mean of 24:1 to 36:1 (Figure 3). This
represents an average increase in the T/N ratio of - 70%. Of









Figure 3 Changes in the tumour to normal liver tissue ratio in
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in the ratio and one showed no change at all. The mean T/N
ratio increased by 158% when an infusion of noradrenaline
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Figure 4 Changes in the tumour to normal liver tissue ratio in
rabbits from noradrenaline to a combination of noradrenaline
and propranolol.
Microsphere distribution
The distribution of microspheres in the normal liver tissue,
in the central regions of the tumour and in the kidneys
before and after drug infusion is presented in Table I. The
introduction of any of the drugs produced no significant
changes in the coefficient of variation from the control
values. The drugs therefore had no effect on the homo-
geneity of embolisation of microspheres in the liver.
Table I Homogeneity of distribution of microspheres within the
normal liver (COV%), percentage difference in counts between
kidneys and the ratio of the central tumour to normal liver (C/N).
Mean tumour diameter is also described for each of the treatment
groups. Mean (±s.d.) * = P<0.05
Treatment COV% C/N Kidneys Diameter
Control 61.3(18.9) 2.1(2.5) 88.1(4.9) 7.7(4.5)
Norad. 67.9(15.0) 2.2(3.3) 90.1(3.9)
Control 50.4(23.2) 1.8(1.8) 93.6(3.0) 5.9(1.8)
Propran. 44.6(16.9) 1.3(1.4) 92.4(3.2)
Control 42.1(16.1) 2.5(3.2) 85.0(8.6) 6.2(4.3)
Nor./Prop. 50.6(17.3) 4.9(5.1)* 93.2(6.3)
Norad. 50.1(17.9) 1.6(1.4) 87.3(14.0) 6.6(3.2)
Nor./Prop. 73.3(21.6) 1.9(0.9) 89.7(12.5)
There were no significant differences measured in the
pattern of embolisation of microspheres in the kidneys for
any of the treatment groups. This demonstrated uniformity
of mixing of microspheres in the aortic blood stream under
both control and drug infusion conditions.
The infusion of noradrenaline or propranolol alone did
not significantly influence the ratio of microspheres
embolised in the tumour centre compared to the normal liver
(C/N). However, combining noradrenaline and propranolol
resulted in a significant (P<0.05) increase in the ratio.
Discussion
The growth of tumour tissue is dependent on the
development of a neovasculature. This develops from pre-
existing normal vessels and morphologically resembles large
tortuous capillaries devoid of smooth muscle and pericytes
(Gerweck, 1985). The vessels develop anatomically but not
physiologically. Regulation of blood flow, blood pressure
and capacitance is lost (Krylova, 1977). However, vaso-
constrictor agents can exert an indirect influence on tumour
blood flow by controlling the arterial supply to tumour
situated in the adjacent normal tissue.
There is conflicting published evidence of the effect of
noradrenaline on tumour blood flow. The i.v. infusion of
noradrenaline into renal tumours in rats has shown a greater
blood flow in tumour relative to normal tissue (Tvete et al.,
1981). However, the T/N ratio in subcutaneous tumours
relative to skin or muscle has been unchanged or decreased
by noradrenaline (Edlich et al., 1966; Hafstrom et al., 1980a;
Mattsson et al., 1980).
Hafstrom and co-workers (1980b) have described small
increases in the T/N ratio in rat liver tumours after
noradrenaline (0.23 to 0.29 and 1.4 to 2.9) and subjective
evidence has been presented of large intrahepatic ratio's in
humans with the drug (Grady et al., 1981). However, the use
of noradrenaline has also been shown by Ackerman (1972)
to have no effect on the T/N ratio in rat liver tumours and it
does not alter access of blood flow to the internal tumour
circulation (Ackerman & Hechmer, 1977). In addition,
Young and co-workers (1979) have shown in both rats and
rabbits substantial reductions in the T/N ratio with
noradrenaline infusion with a dose dependency showing
greater decline with larger doses. Prior beta blockade and
the use of noradrenaline has not been described in terms of a
T/N ratio.
Injection or infusion of noradrenaline into the hepatic
artery has been shown to evoke vasoconstriction in several
species (Greenway et al., 1967; Ross & Kurasch, 1969) by
interaction with alpha-adrenoceptors. However, noradrenaline
also interacts with hepatic beta-adrenoceptors resulting in
arterial vasodilation. It follows that beta blockade increases
the hepatic arterial vasoconstrictor potency of noradrenaline
(Hanson, 1973) and will diminish any vasodilator response
(Richardson & Withrington, 1977b). This enhanced vaso-
constriction has been demonstrated in the present results
where the normal vasculature has been constricted but there
has been a corresponding relative increase in tumour blood
flow. The result is an enhanced T/N ratio with noradrenaline
plus propranolol compared to no response with propranolol
alone or a decrease with noradrenaline alone. The decreased
T/N ratio with noradrenaline alone represents a net
vasodilation in the normal hepatic parenchyma.
The embolisation of microspheres into the central portions
of the tumours was found to be approximately twice that
found in the normal tissue under control conditions. The
introduction of either noradrenaline or propranolol alone
had no effect on this ratio but the two drugs combined
doubled the C/N ratio.
The homogeneity of distribution of embolised micro-
spheres within the liver is described by the coefficient of
variation. The coefficients in this study were found to be
similar to those previously reported in rabbits (Burton et al.,
1985). None of the treatments were found to significantly
alter the coefficient of variation so that the pattern of
distribution in each case was similar and regarded as
relatively homogeneous. This is important because it prevents
the occurrence of local accumulation of microspheres.
We conclude that the blood supply to malignant tumours
in the liver may be indirectly manipulated to advantage
during treatments such as internal radiation therapy or
possibly during regional perfusion chemotherapy. This may
be mediated through the infusion of vasoactive agents such
as noradrenaline and propranolol.
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